1. Home
  2. GTEC vs LIXT Comparison

GTEC vs LIXT Comparison

Compare GTEC & LIXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Greenland Technologies Holding Corporation

GTEC

Greenland Technologies Holding Corporation

HOLD

Current Price

$1.01

Market Cap

21.0M

Sector

Industrials

ML Signal

HOLD

Logo Lixte Biotechnology Holdings Inc.

LIXT

Lixte Biotechnology Holdings Inc.

HOLD

Current Price

$4.06

Market Cap

20.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GTEC
LIXT
Founded
2006
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
21.0M
20.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
GTEC
LIXT
Price
$1.01
$4.06
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
223.8K
85.0K
Earning Date
11-07-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.92
N/A
Revenue
$86,168,664.00
N/A
Revenue This Year
$5.64
N/A
Revenue Next Year
$3.93
N/A
P/E Ratio
$1.04
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.92
$0.64
52 Week High
$2.92
$6.26

Technical Indicators

Market Signals
Indicator
GTEC
LIXT
Relative Strength Index (RSI) 42.32 42.81
Support Level $0.92 $3.53
Resistance Level $1.09 $4.80
Average True Range (ATR) 0.09 0.45
MACD -0.01 -0.01
Stochastic Oscillator 25.71 35.07

Price Performance

Historical Comparison
GTEC
LIXT

About GTEC Greenland Technologies Holding Corporation

Greenland Technologies Holding Corp is a developer of quality solutions in the material handling industry. It is a transmission and drivetrain systems provider for material handling equipment such as forklift trucks for industrial and logistic applications. Geographically, the company has its presence in Domestic and International markets and earns majority of the revenue from Domestic Sales.

About LIXT Lixte Biotechnology Holdings Inc.

Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. It focuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.

Share on Social Networks: